# Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)

> **NCT03596905** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 218 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Constipation

## Interventions

- **DRUG:** Plecanatide
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT03596905
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-30
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596905, "Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03596905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*